Pulsenmore to Announce Full Year 2025 Financial Results
Pulsenmore Ltd. (NASDAQ, TASE: PLSM), a company specializing in home ultrasound technology, announced it will release its financial results for the full year 2025 on March 30, 2026, at 8:30 a.m. Eastern Time.
Financial Results and Conference Call Details
The company will host a conference call and webcast to discuss the financial results, business highlights, and recent progress. The details are as follows:
- Date: March 30, 2026
- Time: 8:30 a.m. Eastern Time / 3:30 p.m. Israel Time
- Webcast Link: https://teams.microsoft.com/meet/3845461353556?p=fcIpXc4mErwEAqo3IrRe
- Replay: A recording of the meeting will be available on the Company’s Investor Relations website at https://pulsenmore.com/investor_relations/
Executive Leadership Participation
Pulsenmore’s executive leadership team will host the call, including:
- Jonathan Adereth, Chairman of the Board of Directors
- Dr. Elazar Sonnenschein, Founder and Chief Executive Officer
- Eran Hirsh, Chief Financial Officer
- Mira Altmark-Sofer, Vice President of Marketing
About Pulsenmore
Pulsenmore Ltd. Focuses on revolutionizing maternal health through the development of home-leverage ultrasound technology that connects mothers and healthcare providers remotely. The company leverages advanced imaging and telemedicine to produce prenatal care more patient-centric, expanding access and improving continuity of care. More information can be found at www.pulsenmore.com.
Forward-Looking Statements
This press release contains forward-looking statements, including those related to commercial momentum, clinician adoption, U.S. Market presence, and access to remote prenatal care. These statements are subject to risks, uncertainties, and contingencies, as detailed in the company’s filings with the SEC, including its Form 20-F filed on December 29, 2025. Pulsenmore undertakes no obligation to update or revise any forward-looking statement.
Investor Contact
Miri Segal-Schari
MS-IR LLC
msegal@ms-ir.com